Shanghai Allist Pharmaceuticals Co Ltd Class A 688578
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥44.22
- Day Range
- ¥44.62–49.19
- 52-Week Range
- ¥32.25–68.87
- Bid/Ask
- ¥48.99 / ¥49.00
- Market Cap
- ¥22.05 Bil
- Volume/Avg
- 4.8 Mil / 4.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.12
- Price/Sales
- 6.97
- Dividend Yield (Trailing)
- 1.47%
- Dividend Yield (Forward)
- 1.47%
- Total Yield
- 1.47%
Company Profile
Shanghai Allist Pharmaceuticals Co Ltd is an innovative drug company in the field of cancer treatment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,044
- Website
- http://www.allist.com.cn
Comparables
Valuation
|
Metric
|
688578
|
688062
|
301207
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.12 | — | 14.58 |
Price/Book Value | 4.41 | 4.06 | 1.72 |
Price/Sales | 6.97 | 57.31 | 4.43 |
Price/Cash Flow | 17.20 | — | 10.76 |
Price/Earnings
688578
688062
301207
Financial Strength
|
Metric
|
688578
|
688062
|
301207
|
|---|---|---|---|
Quick Ratio | 7.39 | 1.53 | 2.85 |
Current Ratio | 7.97 | 1.78 | 3.42 |
Interest Coverage | 14,588.83 | −32.55 | 149.96 |
Quick Ratio
688578
688062
301207
Profitability
|
Metric
|
688578
|
688062
|
301207
|
|---|---|---|---|
Return on Assets (Normalized) | 24.62% | −24.26% | 9.24% |
Return on Equity (Normalized) | 26.90% | −41.90% | 11.52% |
Return on Invested Capital (Normalized) | 25.16% | −26.98% | 10.82% |
Return on Assets
688578
688062
301207
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Nwlkkhct | Pyhwz | $554.5 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Tnlpsnfx | Tyrkzn | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Yrylfbgsw | Cpschd | $114.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Dhsstmnq | Pychzq | $35.2 Bil | |||
| argenx SE ADR
ARGX
| Mykdjzy | Fbs | $31.7 Bil | |||
| BioNTech SE ADR
BNTX
| Qsbtjrxxn | Ppvml | $28.0 Bil | |||
| Moderna Inc
MRNA
| Mpqqzhzh | Stks | $24.6 Bil | |||
| United Therapeutics Corp
UTHR
| Hcftdnblw | Cmc | $15.9 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Hbbsctm | Ktxgsyh | $13.4 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Psnzqtky | Fzjclk | $12.6 Bil |
United States